Star Trek: Khan

Star Trek: Khan

Star Trek: Khan

We estimate there's a 100% chance this podcast is looking for guests- reach out and make your move!

Topic Category:

Fiction, TV and Film

Topic Sub-Category:

Science Fiction

(Log in to see email address)

Language:

English

Podcast Stats:

Number of Episodes: 1
Series Type: serial
Content Type: AUDIO

Podcast Description

History remembers Khan Noonien Singh as a villain, the product of a failed attempt to perfect humanity through genetic engineering whose quest to avenge himself on Admiral James T. Kirk led to unimaginable tragedy and loss. But the truth has been buried for too long beneath the sands of Ceti Alpha V. How did Khan go from a beneficent tyrant and superhuman visionary with a new world at his fingertips to the monster we think we know so well? Recently unearthed, the rest of Khan’s story will finally be told in STAR TREK: KHAN. Premieres September 8.

Podcast Insights

Content Themes

The podcast delves into Khan Noonien Singh's transformation from a benevolent leader and visionary into the iconic villain known from Star Trek II: The Wrath of Khan. Themes include genetic engineering, moral dilemmas of leadership, and the consequences of revenge, with episodes exploring Khan's life on Ceti Alpha V and his interactions with key characters.

Further Podcast insights, such as show format, guest types, ideal guests, and target audience are available to Podcast Collab Club Members!

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.

 

For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.